306 related articles for article (PubMed ID: 9491325)
1. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridization analysis in pathologic organ-confined prostate cancer.
Tsuchiya N; Slezak JM; Lieber MM; Bergstralh EJ; Jenkins RB
Genes Chromosomes Cancer; 2002 Aug; 34(4):363-71. PubMed ID: 12112525
[TBL] [Abstract][Full Text] [Related]
3. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression.
Takahashi S; Shan AL; Ritland SR; Delacey KA; Bostwick DG; Lieber MM; Thibodeau SN; Jenkins RB
Cancer Res; 1995 Sep; 55(18):4114-9. PubMed ID: 7664288
[TBL] [Abstract][Full Text] [Related]
5. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
6. Aneusomies of chromosomes 8 and Y detected by fluorescence in situ hybridization are prognostic markers for pathological stage C (pt3N0M0) prostate carcinoma.
Takahashi S; Alcaraz A; Brown JA; Borell TJ; Herath JF; Bergstralh EJ; Lieber MM; Jenkins RB
Clin Cancer Res; 1996 Jan; 2(1):137-45. PubMed ID: 9816100
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
[TBL] [Abstract][Full Text] [Related]
8. A molecular cytogenetic analysis of 7q31 in prostate cancer.
Jenkins RB; Qian J; Lee HK; Huang H; Hirasawa K; Bostwick DG; Proffitt J; Wilber K; Lieber MM; Liu W; Smith DI
Cancer Res; 1998 Feb; 58(4):759-66. PubMed ID: 9485032
[TBL] [Abstract][Full Text] [Related]
9. Allelic imbalance and microsatellite instability in prostatic adenocarcinoma.
Cunningham JM; Shan A; Wick MJ; McDonnell SK; Schaid DJ; Tester DJ; Qian J; Takahashi S; Jenkins RB; Bostwick DG; Thibodeau SN
Cancer Res; 1996 Oct; 56(19):4475-82. PubMed ID: 8813143
[TBL] [Abstract][Full Text] [Related]
10. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
11. High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy.
Valeri A; Fromont G; Sakr W; Azzouzi R; Dey J; Chantrel-Groussard K; Latil A; Berthon P; Cussenot O; Pontes JE; Cher ML
Urol Oncol; 2005; 23(2):87-92. PubMed ID: 15869992
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of chromosome 8p, 10q, and 16q deletions in prostate cancer.
Matsuyama H; Pan Y; Yoshihiro S; Kudren D; Naito K; Bergerheim US; Ekman P
Prostate; 2003 Feb; 54(2):103-11. PubMed ID: 12497583
[TBL] [Abstract][Full Text] [Related]
13. Association of allelic loss on 1q, 4p, 7q, 9p, 9q, and 16q with postoperative death in papillary thyroid carcinoma.
Kitamura Y; Shimizu K; Tanaka S; Ito K; Emi M
Clin Cancer Res; 2000 May; 6(5):1819-25. PubMed ID: 10815903
[TBL] [Abstract][Full Text] [Related]
14. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
[TBL] [Abstract][Full Text] [Related]
15. Differential chromosome allelic imbalance in the progression of human prostate cancer.
Latil A; Fournier G; Cussenot O; Lidereau R
J Urol; 1996 Dec; 156(6):2079-83. PubMed ID: 8911394
[TBL] [Abstract][Full Text] [Related]
16. [Frequent allelic losses in tumor-associated stromal cells and tumor epitelium of prostate cancer].
Kekeeva TV; Popova OP; Shegaĭ PV; Zavalishina LE; Andreeva IuIu; Zaletaev DV; Nemtsova MV
Mol Biol (Mosk); 2008; 42(1):96-101. PubMed ID: 18389625
[TBL] [Abstract][Full Text] [Related]
17. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
[TBL] [Abstract][Full Text] [Related]
18. Allelic imbalance and biochemical outcome after radical prostatectomy.
Bott SR; Masters JR; Parkinson MC; Kirby RS; Feneley M; Hooper J; Williamson M
Prostate Cancer Prostatic Dis; 2006; 9(2):160-8. PubMed ID: 16534511
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
20. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
